ID   1.1.1.100
DE   3-oxoacyl-[acyl-carrier-protein] reductase.
CA   a (3R)-hydroxyacyl-[ACP] + NADP(+) = a 3-oxoacyl-[ACP] + H(+) + NADPH.
CC   -!- Exhibits a marked preference for [acyl-carrier-protein] derivatives
CC       over CoA derivatives as substrates.
DR   Q8TGA2, AFLA_ASPPU ;  Q5AV00, ATNF_EMENI ;  A4IFA7, CBR4_BOVIN ;
DR   Q8N4T8, CBR4_HUMAN ;  Q91VT4, CBR4_MOUSE ;  Q7TS56, CBR4_RAT   ;
DR   Q93X62, FABG1_BRANA;  Q93X67, FABG2_BRANA;  Q949M3, FABG3_BRANA;
DR   Q949M2, FABG4_BRANA;  Q93X68, FABG5_BRANA;  P27582, FABG6_BRANA;
DR   P70720, FABG_AGGAC ;  O67610, FABG_AQUAE ;  P33207, FABG_ARATH ;
DR   P51831, FABG_BACSU ;  P57432, FABG_BUCAI ;  Q8K9J5, FABG_BUCAP ;
DR   Q89AG9, FABG_BUCBP ;  Q9PKF7, FABG_CHLMU ;  Q9Z8P2, FABG_CHLPN ;
DR   P38004, FABG_CHLTR ;  P28643, FABG_CUPLA ;  P0AEK2, FABG_ECOLI ;
DR   P43713, FABG_HAEIN ;  P27583, FABG_PERAE ;  O54438, FABG_PSEAE ;
DR   Q1RKB7, FABG_RICBR ;  Q92GE0, FABG_RICCN ;  Q4UK62, FABG_RICFE ;
DR   P50941, FABG_RICPR ;  Q68VY7, FABG_RICTY ;  P0A2D0, FABG_SALTI ;
DR   P0A2C9, FABG_SALTY ;  O42866, FABG_SCHPO ;  P0AEK3, FABG_SHIFL ;
DR   Q5HGK2, FABG_STAAC ;  P0A0H9, FABG_STAAM ;  P99093, FABG_STAAN ;
DR   Q6GHK4, FABG_STAAR ;  Q6G9Y2, FABG_STAAS ;  P0A0I0, FABG_STAAW ;
DR   Q5HPW0, FABG_STAEQ ;  Q8CPI3, FABG_STAES ;  P73574, FABG_SYNY3 ;
DR   Q9X248, FABG_THEMA ;  Q9KQH7, FABG_VIBCH ;  P55336, FABG_VIBHA ;
DR   P35731, FABG_YEAST ;  P43098, FAS2_CANAX ;  G8BAW7, FAS2_CANPC ;
DR   P78615, FAS2_EMEND ;  Q765N2, FAS2_LACKL ;  P15368, FAS2_PENPA ;
DR   Q10289, FAS2_SCHPO ;  P19097, FAS2_YEAST ;  Q71SP7, FAS_BOVIN  ;
DR   P12276, FAS_CHICK  ;  P49327, FAS_HUMAN  ;  P19096, FAS_MOUSE  ;
DR   P12785, FAS_RAT    ;  I1R9A6, GRA9_GIBZE ;  A7TUG9, HEXA_DOTSE ;
DR   M2YJJ3, HEXA_DOTSN ;  O07399, MABA_MYCAV ;  P0A5Y5, MABA_MYCBO ;
DR   P71534, MABA_MYCS2 ;  P9WGT2, MABA_MYCTO ;  P9WGT3, MABA_MYCTU ;
DR   Q2TXF0, ORYA_ASPOR ;  Q5B7V0, PKIB_EMENI ;  Q9RPT1, RHLG_PSEAE ;
DR   Q00681, STCJ_EMENI ;  S5NIA2, TOXH_COCCA ;
//